Dennis J. Ahnen, MD

Research Interests:

Dr. Ahnen’s research interess include the biologic and the biochemical mechanisms of the chemopreventive effects of the non-steroidal anti-inflammatory drugs (NSAIDs). He is currently examining the effect of NSAIDs on EGF receptor expression and function. His clinical trials group participates in several colorectal cancer prevention trials including several adenoma chemoprevention trials. He also collaborates with Al Marcus PhD and staff at the AMC Cancer Research Center to evaluate behavioral interventions to increase colorectal cancer screening rates in high-risk populations and he directs the Colorado site for two national cancer registries that identify high risk families for genetic and clinical trials.

Education:

Undergraduate: Florida State University

Medical School: Wayne State University

Fellowship: Gastroenterology University of Colorado Denver

Fellowship: Membrane Pathobiology, Stanford University

Representative Publication:

Chemoprevention of hereditary colon cancers: time for new strategies

Familial colon cancer syndromes: an update of a rapidly evolving field